Recent advances in the treatment of Acanthamoeba keratitis.
Infection of the eye caused by Acanthamoeba species constitutes a burgeoning and unsolved problem. Of individuals with Acanthamoeba keratitis, 85% wear contact lenses; abrasion of the cornea is implicated. Corneal infection often can be prevented by good lens care and hygiene. Severe Acanthamoeba keratitis often can be very difficult to treat; surgery can be less than successful and may lead to further problems. The encysted stage in the life cycle of Acanthamoeba species appears to cause the most problems; many biocides are ineffective in killing the highly resistant cysts. Combination therapy--that is, use of 2 or 3 biocides, sometimes with antibacterial antibiotics--appears to work best. Recurrence is common if treatment is stopped prematurely. Immunologic methods are being investigated as a form of prevention, and oral immunization of animals recently has been successful in the prevention of Acanthamoeba keratitis by inducing immunity before infection occurs. Immunization thus may eventually become the best approach for reduction of the incidence of amebic infection in humans.
Kumar
Raman
R
Department of Microbiology, Cardiff University, Wales, United Kingdom.
Lloyd
David
D
D000048:Acanthamoeba / Q000187:drug effects / Q000276:immunology / Q000472:pathogenicity; D015823:Acanthamoeba Keratitis / Q000453:epidemiology / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D000818:Animals; D000981:Antiprotozoal Agents / Q000494:pharmacology; D002448:Cell Adhesion; D016039:Corneal Transplantation; D004351:Drug Resistance; D006801:Humans; D007114:Immunization; D007171:Implosive Therapy
D000981:Antiprotozoal Agents